Latest Intermetro Communica (IMTO) Headlines
Breast Imaging Technologies Market worth $5 Billion by 2017
M2 - 31 mins ago
According to a new market research report "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017" , is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation.
Canon Congratulates the Team of Imaging Professionals Who Captured the Iconic Moments of the Big Game
Business Wire - Thu Feb 06, 3:54PM CST
On February 2nd imaging professionals from across the country gathered in New Jersey to cover the big game between teams from Seattle and Denver. Prepared to battle the potential elements, these professionals provided football fans with images documenting monumental moments and plays that can be watched, enjoyed and relived for years to come.
Merge Healthcare Licenses Zero Footprint Patent Portfolio From Heart Imaging Technologies
GlobeNewswire - Tue Jan 14, 6:00AM CST
Merge Healthcare Incorporated (Nasdaq:MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, and Heart Imaging Technologies (Heart IT), an industry leader in web-based medical image viewing and management solutions, today announced they have entered into a non-exclusive patent license and settlement agreement.
Canon Introduces New Lineup of Multi-Purpose VIXIA HF R-Series Camcorders
Business Wire - Mon Jan 06, 9:03AM CST
Canon U.S.A., Inc., a leader in digital imaging solutions, has revamped the VIXIA HF R-Series lineup of camcorders with the announcement of three new models, the VIXIA HF R52, VIXIA HF R50 and VIXIA HF R500 camcorders. The new VIXIA HF R-Series camcorders all feature a 57x Advanced Zoom, an upgrade from previous VIXIA R-Series HF camcorders, along with SuperRange Optical Image Stabilization, a Canon 3.28 Megapixel Full HD CMOS Image Sensor, and three-inch capacitive touch panel LCD. The VIXIA HF R52 and VIXIA HF R50 camcorder models feature advanced Wi-Fi capabilities as compared to their predecessor models, enabling them to also function as remote monitoring devices at home or outside the home with mobile internet access.
Imagine, Create and Share with Canon's Imaging Solutions at the 2014 Consumer Electronics Show
Business Wire - Mon Jan 06, 9:01AM CST
At the Consumer Electronics Show (CES) in Las Vegas, January 7th -10th, Canon U.S.A., Inc., a leader in digital imaging solutions, will showcase its latest consumer and professional products through a theme of "Dreamers Welcome." Attendees to the booth (#13304 in the Central Hall) will experience inspiring visual displays and interactive product demonstration areas that will inspire attendees to create and share in addition to learning from professional photographer speakers. Attendees will also have the opportunity to view several short films from "Project Imaginat10n," Canon's latest film festival inspired by user-generated photographs at the Project Imaginat10n Theater located in the booth, along with a gallery of images from the PIXMA PRO City Senses tour.
New Sleek, Compact PowerShot Digital Cameras Offer Super-Zoom Lenses, Advanced Connectivity Options and the Ability to Share Images and Video
Business Wire - Mon Jan 06, 8:29AM CST
Canon U.S.A., Inc., a leader in digital imaging solutions, today announced the addition of two new cameras to its PowerShot line-up: The PowerShot SX600 HS and the PowerShot ELPH 340 HS digital cameras. The PowerShot SX600 HS camera packs an impressive 18x optical zoom and 16-Megapixel High-Sensitivity CMOS sensor into a beautifully sleek, compact and portable body so capturing close-up photos with high-image clarity is easy and stylish. The PowerShot ELPH 340 HS camera offers outstanding optical performance and versatility with a 12x optical zoom lens and16-Megapixel High-Sensitivity CMOS sensor. Both equipped with Wi-Fi(R) and Near Field Communication (NFC(TM)) capabilities, photographers can have outstanding image quality and the ability to share images and video with ease.
Breast Imaging Technologies Market Worth $5 Billion by 2017 Forecasted in MarketsandMarkets Recent Report
Marketwire Canada - Tue Dec 24, 4:30AM CST
According to report "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017" by MarketsandMarkets, defines and segments the Breast Imaging Technologies Market with analysis and forecasting of the global revenue.
Canon Receives Highest Ranking in Customer Satisfaction for Multi-Function Inkjet Printers in the 2013 J.D. Power Satisfaction Report
Business Wire - Tue Dec 17, 8:23AM CST
Canon U.S.A., Inc., a leader in digital imaging solutions, is proud to announce that Canon has received top honors in Customer Satisfaction from J.D. Power for its line of PIXMA Multi-Function Inkjet Printers.(1)
Breast Imaging Technologies Market (Digital Mammography, Molecular Breast Imaging) worth $5 Billion - 2017
M2 - Mon Dec 16, 4:30AM CST
According to a new market research report "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017" , is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation. Ionizing breast imaging modalities include Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI), Positron Emission Tomography (PET) and Breast Specific Gamma Imaging (BSGI). The various Non-ionizing modalities for breast screening covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.
Smart Imaging Technologies and InvitroCue Team Up to Bring Digital Pathology to Asia
PRWeb - Tue Dec 10, 7:10AM CST
Smart Imaging Technologies Co and InvitroCue launch strategic partnership to offer Digital Pathology services in Singapore and other Asian countries. Services include digital slide scanning, archival, advanced tissue image analytics and remote pathology consultation network.
Diastology, Valve & New Imaging Technologies Summit
M2 - Mon Dec 02, 3:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/vnmkjh/diastology_valve) has announced the addition of the "Diastology, Valve & New Imaging Technologies Summit" training to their offering. The Cleveland Clinic Diastology, Valve and New Echo Technologies Summit activity is now available in a variety of multimedia formats to meet your continuing education needs digital, DVD, MP4, audio CD, and MP3. Cleveland Clinic's Diastology, Valve and New Imaging Technologies Summit provides a unique opportunity to listen to key opinion leaders and receive updates in heart valve disease, new imaging technologies, diastology, and multimodality imaging. The Summit is divided into the following four parts: - Heart Valve Disease presents a state-of-the-art mini symposium on new advances in valvular heart disease including epidemiology, clinical diagnostic approaches to mitral, tricuspid, and aortic regurgitation and aortic stenosis, as well as new approaches to valve repair including robotics and percutaneous and transcatheter techniques. - New Imaging Technologies highlights new and emerging applications in 3-D and 4-D echo, real time 3-D TEE, 2-D strain, stress echo, cardiac resynchronization, contrast echocardiography, and interventional echo. - Diastology presents a basic and advanced summit on diastolic heart failure including new guidelines, epidemiology, clinical diagnostic approaches, specific diseases and effects of therapy of diastolic heart failure, hemodynamic monitoring, and clinical trials. - Multimodality Imaging presents a state-of-the-art mini symposium on the basic principles of multimodality imaging, including CT and cardiac MR, as well as clinical applications in coronary artery disease, cardiomyopathies, viability, and aortic diseases. Intended Audience This activity is designed for physicians preparing for non-invasive and invasive cardiologists, cardiac surgeons, anesthesiologists, sonographers, physician assistants, nurses, fellows, and other healthcare professionals interested in heart valve disease, new echo technologies, diastology, and multimodality imaging. Learning Objectives Heart Valve Disease New Imaging Technologies Diastology Multimodality Imaging Accreditation The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 20.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Release date: July 1, 2013 Expiration date: November 30, 2015 CME credit is obtained upon successful completion of an online posttest and evaluation, as well as payment of a $30 processing fee. Faculty Disclosure The Cleveland Clinic Foundation Center for Continuing Education ?has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will ?be identified in the activity syllabus. For more information visit http://www.researchandmarkets.com/research/vn...logy_valve About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
FluoroPharma Medical Inc. Is Elected to the Medical Imaging & Technology Alliance (MITA)
Marketwire - Mon Nov 25, 8:54AM CST
FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, announced today that it has been elected to MITA and will be represented by Edward L. Lyons, Vice President of Marketing. Mr. Lyons is responsible for the global development and commercial strategy for FluoroPharma's nuclear cardiology portfolio.
Canon Introduces DP-V3010 4K Reference Display for Digital Cinema Color-Grading and 4K / 2K Postproduction and Effects Monitoring
Business Wire - Wed Nov 06, 7:07PM CST
As motion picture, television and commercial production continues to transition to ever-higher resolution digital video and CGI (computer graphic imaging) formats, color-grading and postproduction professionals increasingly rely on reference displays with exceptional detail, color and gradation accuracy. Developed in response to this trend is the new DP-V3010 4K Reference Display from Canon U.S.A., Inc., a leader in digital imaging solutions. The Canon DP-V3010 4K Reference Display measures 30 inches wide diagonally by 7.4 inches deep to help minimize space requirements and provides a 2000:1 DCI-compliant contrast ratio, uniform brightness, very wide viewing angles in all four directions, internal color calibration and additional advanced features. Designed for use in color-grading, digital intermediate (DI), CGI/animation/visual effects (VFX), and editing/finishing suites, as well as digital imaging technician (DIT) workstations on production stages and on-location "video villages," the Canon DP-V3010 4K Reference Display provides full-screen 4096 x 2560 resolution with extremely high levels of color accuracy and fidelity.
Breast Imaging Technologies Market - Technology and Market Analysis & Global Forecasts to 2017
GlobeNewswire - Tue Nov 05, 8:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/gkfx57/breast_imaging) has announced the addition of the "Breast Imaging Technologies Market (Digital Mammography,3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017" report to their offering.
Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI) Worth $5 Billion - 2017 - New Report by MarketsandMarkets
PRWeb - Sat Nov 02, 11:01AM CDT
According to a new market research report "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017", is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation. Ionizing breast imaging modalities include Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI), Positron Emission Tomography (PET) and Breast Specific Gamma Imaging (BSGI). The various Non-ionizing modalities for breast screening covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.
Canon Firmware Upgrades for the EOS-1D X and EOS-1D C Digital SLR Cameras Deliver Improved Creative Control and Convenience
Business Wire - Tue Oct 22, 3:00AM CDT
Canon U.S.A., Inc., a leader in digital imaging solutions, announces improvements in the functionality and convenient operation of the EOS-1D X Digital SLR camera and the EOS-1D C Digital SLR Cinema camera through new firmware scheduled to be available starting in January 2014 and November 2013, respectively. Firmware enhancements for the EOS-1D X Digital SLR camera are designed to provide photographers with greater creative freedom and speed, especially in sectors such as sports, wedding, nature/wildlife, and journalism, which often contain rapidly changing action, sometimes in low-light environments. Service enhancements for the EOS-1D C Digital SLR Cinema camera improve lens performance, lens status display, metadata storage, and audio recording.
Global Biomarkers Market Report to 2018: Discovery Technologies , Validation Services, Applications & Diseases
M2 - Mon Oct 14, 10:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gb5h4l/biomarkers_market) has announced the addition of the "Biomarkers Market - Discovery Technologies , Validation Services, Applications & Diseases - Global Trends & Forecasts (2013 - 2018)" report to their offering. The global biomarkers market shows a high growth potential and accounts for $17.5 billion in 2013. It is expected to grow at a CAGR of 18.5% from 2013 to 2018, to reach $40.8 billion by 2018. Advancements in discovery technologies, high demand from the indications of various diseases, increasing partnerships and collaborations to boost biomarker research activities, increase in government and private sector investments and funds for biomarker discovery, FDA support for biomarker development, and increasing utility of biomarkers in patient stratification and drug development process are the major drivers poised to propel the growth of this market. However, a few pivotal factors such as the high capital investment and low benefit-cost ratio, cumbersome biomarker validation procedure, and difficulty in sample collection and its storage are expected to hamper the growth of this market. The global market has been segmented into discovery technologies, services, applications, and disease indications. The biomarker discovery technology market has been further segmented into omics technology, imaging technology, and bioinformatics. The omics technology segment accounts for the largest share in this market, primarily due to the increase in adoption of proteomics and genomics technologies across the globe. In addition, the biomarker services (sample preparation, assay development, and biomarker validation and testing) and applications (drug discovery and formulation, and development of molecular diagnostics and personalized medicine) market have also been illustrated in the report. Drug discovery and development segment holds the largest share of biomarker applications market. This is attributed to the potential of biomarkers to reduce the time span of clinical trials, which ultimately decreases the overall cost of the entire drug discovery and development process. On the basis of type of disease, the global biomarkers market is further classified as oncology, cardiology, neurology, and other diseases (HIV, renal disorders, diabetes, arthritis, and tuberculosis). Oncology biomarkers market accounts for the lion's share of the biomarker disease indication market and further this market is forecast to grow at the highest growth rate in the next five years. Increasing need for the early diagnosis of tumor cells is the major factor stimulating the growth of oncology market. Oncology biomarkers enhance the screening and early detection of cancer as well as facilitate the high-speed, non-invasive cancer diagnosis procedure. The key players in this market are Roche Diagnostics Limited (Switzerland), Johnson & Johnson (U.S.), GlaxoSmithKline, Plc. (U.K.), Siemens Healthcare (Germany), Abbott Laboratories, Inc. (U.S.), GE Healthcare (U.K.), Affymetrix, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Epigenomics AG (Germany), Eisai Co. Ltd. (Japan), Bio-Rad Laboratories, Inc. (U.S.), Eli Lilly and Company (U.S.), Merck & Co. (U.S.), Genomic Health, Inc. (U.S.), and Agilent Technologies Inc. (U.S.) Scope of the Report Discovery Technologies - Imaging Technologies - Omics Technologies -- Proteomics -- Genomics -- Transcriptomics -- Metabolomics - Bioinformatics Services - Sample Preparation - Assay Development - Biomarker Validation and Testing Applications - Drug Discovery and Development - Personalized Medicine - Molecular Diagnostics - Other Applications Disease Indications - Oncology - Cardiology - Neurology - Others Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Biomarkers Market, By Discovery Technologies 5 Services Market Of Biomarkers 6 Biomarkers Application Market 7 Biomarkers Indication Market 8 Geographical Analysis 9 Competitive Landscape 10 Company Profiles For more information visit http://www.researchandmarkets.com/research/gb...ers_market
Segoma Imaging Technologies to Photograph De Beers Diamonds for Online Auctions
PR Newswire - Wed Aug 28, 1:33PM CDT
Segoma Imaging Technologies, the leader in 360-degree Diamond Display Technology, recently announced they would be photographing large stones for De Beers' online auction website. This partnership marks another landmark for Segoma - they are already photographing Rio Tinto's Argyle Pink Diamonds for their monthly tenders. The images, which are displayed on The Argyle Pink Website, flawlessly capture the exact color of these fancy diamonds.
Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) -Technology and Market Analysis & Global Forecasts to 2017
M2 - Fri Aug 16, 3:20AM CDT
The global breast imaging market holds a significant share of the medical device industry owing to rising awareness about the early screening of breast cancer. Though digital Mammography is the gold standard in the current breast imaging market, modalities such as breast MRI Scans, breast ultrasound and CTs are expected to drastically improve the breast Imaging Market scenario.
Breast Imaging Technologies Market worth $5 Billion by 2017
M2 - 31 mins ago
According to a new market research report "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017" , is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation.
Canon Congratulates the Team of Imaging Professionals Who Captured the Iconic Moments of the Big Game
Business Wire - Thu Feb 06, 3:54PM CST
On February 2nd imaging professionals from across the country gathered in New Jersey to cover the big game between teams from Seattle and Denver. Prepared to battle the potential elements, these professionals provided football fans with images documenting monumental moments and plays that can be watched, enjoyed and relived for years to come.
Merge Healthcare Licenses Zero Footprint Patent Portfolio From Heart Imaging Technologies
GlobeNewswire - Tue Jan 14, 6:00AM CST
Merge Healthcare Incorporated (Nasdaq:MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, and Heart Imaging Technologies (Heart IT), an industry leader in web-based medical image viewing and management solutions, today announced they have entered into a non-exclusive patent license and settlement agreement.
Canon Introduces New Lineup of Multi-Purpose VIXIA HF R-Series Camcorders
Business Wire - Mon Jan 06, 9:03AM CST
Canon U.S.A., Inc., a leader in digital imaging solutions, has revamped the VIXIA HF R-Series lineup of camcorders with the announcement of three new models, the VIXIA HF R52, VIXIA HF R50 and VIXIA HF R500 camcorders. The new VIXIA HF R-Series camcorders all feature a 57x Advanced Zoom, an upgrade from previous VIXIA R-Series HF camcorders, along with SuperRange Optical Image Stabilization, a Canon 3.28 Megapixel Full HD CMOS Image Sensor, and three-inch capacitive touch panel LCD. The VIXIA HF R52 and VIXIA HF R50 camcorder models feature advanced Wi-Fi capabilities as compared to their predecessor models, enabling them to also function as remote monitoring devices at home or outside the home with mobile internet access.
Imagine, Create and Share with Canon's Imaging Solutions at the 2014 Consumer Electronics Show
Business Wire - Mon Jan 06, 9:01AM CST
At the Consumer Electronics Show (CES) in Las Vegas, January 7th -10th, Canon U.S.A., Inc., a leader in digital imaging solutions, will showcase its latest consumer and professional products through a theme of "Dreamers Welcome." Attendees to the booth (#13304 in the Central Hall) will experience inspiring visual displays and interactive product demonstration areas that will inspire attendees to create and share in addition to learning from professional photographer speakers. Attendees will also have the opportunity to view several short films from "Project Imaginat10n," Canon's latest film festival inspired by user-generated photographs at the Project Imaginat10n Theater located in the booth, along with a gallery of images from the PIXMA PRO City Senses tour.
New Sleek, Compact PowerShot Digital Cameras Offer Super-Zoom Lenses, Advanced Connectivity Options and the Ability to Share Images and Video
Business Wire - Mon Jan 06, 8:29AM CST
Canon U.S.A., Inc., a leader in digital imaging solutions, today announced the addition of two new cameras to its PowerShot line-up: The PowerShot SX600 HS and the PowerShot ELPH 340 HS digital cameras. The PowerShot SX600 HS camera packs an impressive 18x optical zoom and 16-Megapixel High-Sensitivity CMOS sensor into a beautifully sleek, compact and portable body so capturing close-up photos with high-image clarity is easy and stylish. The PowerShot ELPH 340 HS camera offers outstanding optical performance and versatility with a 12x optical zoom lens and16-Megapixel High-Sensitivity CMOS sensor. Both equipped with Wi-Fi(R) and Near Field Communication (NFC(TM)) capabilities, photographers can have outstanding image quality and the ability to share images and video with ease.
Breast Imaging Technologies Market Worth $5 Billion by 2017 Forecasted in MarketsandMarkets Recent Report
Marketwire Canada - Tue Dec 24, 4:30AM CST
According to report "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017" by MarketsandMarkets, defines and segments the Breast Imaging Technologies Market with analysis and forecasting of the global revenue.
Canon Receives Highest Ranking in Customer Satisfaction for Multi-Function Inkjet Printers in the 2013 J.D. Power Satisfaction Report
Business Wire - Tue Dec 17, 8:23AM CST
Canon U.S.A., Inc., a leader in digital imaging solutions, is proud to announce that Canon has received top honors in Customer Satisfaction from J.D. Power for its line of PIXMA Multi-Function Inkjet Printers.(1)
Breast Imaging Technologies Market (Digital Mammography, Molecular Breast Imaging) worth $5 Billion - 2017
M2 - Mon Dec 16, 4:30AM CST
According to a new market research report "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017" , is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation. Ionizing breast imaging modalities include Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI), Positron Emission Tomography (PET) and Breast Specific Gamma Imaging (BSGI). The various Non-ionizing modalities for breast screening covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.
Smart Imaging Technologies and InvitroCue Team Up to Bring Digital Pathology to Asia
PRWeb - Tue Dec 10, 7:10AM CST
Smart Imaging Technologies Co and InvitroCue launch strategic partnership to offer Digital Pathology services in Singapore and other Asian countries. Services include digital slide scanning, archival, advanced tissue image analytics and remote pathology consultation network.
Diastology, Valve & New Imaging Technologies Summit
M2 - Mon Dec 02, 3:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/vnmkjh/diastology_valve) has announced the addition of the "Diastology, Valve & New Imaging Technologies Summit" training to their offering. The Cleveland Clinic Diastology, Valve and New Echo Technologies Summit activity is now available in a variety of multimedia formats to meet your continuing education needs digital, DVD, MP4, audio CD, and MP3. Cleveland Clinic's Diastology, Valve and New Imaging Technologies Summit provides a unique opportunity to listen to key opinion leaders and receive updates in heart valve disease, new imaging technologies, diastology, and multimodality imaging. The Summit is divided into the following four parts: - Heart Valve Disease presents a state-of-the-art mini symposium on new advances in valvular heart disease including epidemiology, clinical diagnostic approaches to mitral, tricuspid, and aortic regurgitation and aortic stenosis, as well as new approaches to valve repair including robotics and percutaneous and transcatheter techniques. - New Imaging Technologies highlights new and emerging applications in 3-D and 4-D echo, real time 3-D TEE, 2-D strain, stress echo, cardiac resynchronization, contrast echocardiography, and interventional echo. - Diastology presents a basic and advanced summit on diastolic heart failure including new guidelines, epidemiology, clinical diagnostic approaches, specific diseases and effects of therapy of diastolic heart failure, hemodynamic monitoring, and clinical trials. - Multimodality Imaging presents a state-of-the-art mini symposium on the basic principles of multimodality imaging, including CT and cardiac MR, as well as clinical applications in coronary artery disease, cardiomyopathies, viability, and aortic diseases. Intended Audience This activity is designed for physicians preparing for non-invasive and invasive cardiologists, cardiac surgeons, anesthesiologists, sonographers, physician assistants, nurses, fellows, and other healthcare professionals interested in heart valve disease, new echo technologies, diastology, and multimodality imaging. Learning Objectives Heart Valve Disease New Imaging Technologies Diastology Multimodality Imaging Accreditation The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 20.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Release date: July 1, 2013 Expiration date: November 30, 2015 CME credit is obtained upon successful completion of an online posttest and evaluation, as well as payment of a $30 processing fee. Faculty Disclosure The Cleveland Clinic Foundation Center for Continuing Education ?has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will ?be identified in the activity syllabus. For more information visit http://www.researchandmarkets.com/research/vn...logy_valve About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
FluoroPharma Medical Inc. Is Elected to the Medical Imaging & Technology Alliance (MITA)
Marketwire - Mon Nov 25, 8:54AM CST
FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, announced today that it has been elected to MITA and will be represented by Edward L. Lyons, Vice President of Marketing. Mr. Lyons is responsible for the global development and commercial strategy for FluoroPharma's nuclear cardiology portfolio.
Canon Introduces DP-V3010 4K Reference Display for Digital Cinema Color-Grading and 4K / 2K Postproduction and Effects Monitoring
Business Wire - Wed Nov 06, 7:07PM CST
As motion picture, television and commercial production continues to transition to ever-higher resolution digital video and CGI (computer graphic imaging) formats, color-grading and postproduction professionals increasingly rely on reference displays with exceptional detail, color and gradation accuracy. Developed in response to this trend is the new DP-V3010 4K Reference Display from Canon U.S.A., Inc., a leader in digital imaging solutions. The Canon DP-V3010 4K Reference Display measures 30 inches wide diagonally by 7.4 inches deep to help minimize space requirements and provides a 2000:1 DCI-compliant contrast ratio, uniform brightness, very wide viewing angles in all four directions, internal color calibration and additional advanced features. Designed for use in color-grading, digital intermediate (DI), CGI/animation/visual effects (VFX), and editing/finishing suites, as well as digital imaging technician (DIT) workstations on production stages and on-location "video villages," the Canon DP-V3010 4K Reference Display provides full-screen 4096 x 2560 resolution with extremely high levels of color accuracy and fidelity.
Breast Imaging Technologies Market - Technology and Market Analysis & Global Forecasts to 2017
GlobeNewswire - Tue Nov 05, 8:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/gkfx57/breast_imaging) has announced the addition of the "Breast Imaging Technologies Market (Digital Mammography,3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017" report to their offering.
Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI) Worth $5 Billion - 2017 - New Report by MarketsandMarkets
PRWeb - Sat Nov 02, 11:01AM CDT
According to a new market research report "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017", is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation. Ionizing breast imaging modalities include Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI), Positron Emission Tomography (PET) and Breast Specific Gamma Imaging (BSGI). The various Non-ionizing modalities for breast screening covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.
Canon Firmware Upgrades for the EOS-1D X and EOS-1D C Digital SLR Cameras Deliver Improved Creative Control and Convenience
Business Wire - Tue Oct 22, 3:00AM CDT
Canon U.S.A., Inc., a leader in digital imaging solutions, announces improvements in the functionality and convenient operation of the EOS-1D X Digital SLR camera and the EOS-1D C Digital SLR Cinema camera through new firmware scheduled to be available starting in January 2014 and November 2013, respectively. Firmware enhancements for the EOS-1D X Digital SLR camera are designed to provide photographers with greater creative freedom and speed, especially in sectors such as sports, wedding, nature/wildlife, and journalism, which often contain rapidly changing action, sometimes in low-light environments. Service enhancements for the EOS-1D C Digital SLR Cinema camera improve lens performance, lens status display, metadata storage, and audio recording.
Global Biomarkers Market Report to 2018: Discovery Technologies , Validation Services, Applications & Diseases
M2 - Mon Oct 14, 10:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gb5h4l/biomarkers_market) has announced the addition of the "Biomarkers Market - Discovery Technologies , Validation Services, Applications & Diseases - Global Trends & Forecasts (2013 - 2018)" report to their offering. The global biomarkers market shows a high growth potential and accounts for $17.5 billion in 2013. It is expected to grow at a CAGR of 18.5% from 2013 to 2018, to reach $40.8 billion by 2018. Advancements in discovery technologies, high demand from the indications of various diseases, increasing partnerships and collaborations to boost biomarker research activities, increase in government and private sector investments and funds for biomarker discovery, FDA support for biomarker development, and increasing utility of biomarkers in patient stratification and drug development process are the major drivers poised to propel the growth of this market. However, a few pivotal factors such as the high capital investment and low benefit-cost ratio, cumbersome biomarker validation procedure, and difficulty in sample collection and its storage are expected to hamper the growth of this market. The global market has been segmented into discovery technologies, services, applications, and disease indications. The biomarker discovery technology market has been further segmented into omics technology, imaging technology, and bioinformatics. The omics technology segment accounts for the largest share in this market, primarily due to the increase in adoption of proteomics and genomics technologies across the globe. In addition, the biomarker services (sample preparation, assay development, and biomarker validation and testing) and applications (drug discovery and formulation, and development of molecular diagnostics and personalized medicine) market have also been illustrated in the report. Drug discovery and development segment holds the largest share of biomarker applications market. This is attributed to the potential of biomarkers to reduce the time span of clinical trials, which ultimately decreases the overall cost of the entire drug discovery and development process. On the basis of type of disease, the global biomarkers market is further classified as oncology, cardiology, neurology, and other diseases (HIV, renal disorders, diabetes, arthritis, and tuberculosis). Oncology biomarkers market accounts for the lion's share of the biomarker disease indication market and further this market is forecast to grow at the highest growth rate in the next five years. Increasing need for the early diagnosis of tumor cells is the major factor stimulating the growth of oncology market. Oncology biomarkers enhance the screening and early detection of cancer as well as facilitate the high-speed, non-invasive cancer diagnosis procedure. The key players in this market are Roche Diagnostics Limited (Switzerland), Johnson & Johnson (U.S.), GlaxoSmithKline, Plc. (U.K.), Siemens Healthcare (Germany), Abbott Laboratories, Inc. (U.S.), GE Healthcare (U.K.), Affymetrix, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Epigenomics AG (Germany), Eisai Co. Ltd. (Japan), Bio-Rad Laboratories, Inc. (U.S.), Eli Lilly and Company (U.S.), Merck & Co. (U.S.), Genomic Health, Inc. (U.S.), and Agilent Technologies Inc. (U.S.) Scope of the Report Discovery Technologies - Imaging Technologies - Omics Technologies -- Proteomics -- Genomics -- Transcriptomics -- Metabolomics - Bioinformatics Services - Sample Preparation - Assay Development - Biomarker Validation and Testing Applications - Drug Discovery and Development - Personalized Medicine - Molecular Diagnostics - Other Applications Disease Indications - Oncology - Cardiology - Neurology - Others Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Biomarkers Market, By Discovery Technologies 5 Services Market Of Biomarkers 6 Biomarkers Application Market 7 Biomarkers Indication Market 8 Geographical Analysis 9 Competitive Landscape 10 Company Profiles For more information visit http://www.researchandmarkets.com/research/gb...ers_market
Segoma Imaging Technologies to Photograph De Beers Diamonds for Online Auctions
PR Newswire - Wed Aug 28, 1:33PM CDT
Segoma Imaging Technologies, the leader in 360-degree Diamond Display Technology, recently announced they would be photographing large stones for De Beers' online auction website. This partnership marks another landmark for Segoma - they are already photographing Rio Tinto's Argyle Pink Diamonds for their monthly tenders. The images, which are displayed on The Argyle Pink Website, flawlessly capture the exact color of these fancy diamonds.
Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) -Technology and Market Analysis & Global Forecasts to 2017
M2 - Fri Aug 16, 3:20AM CDT
The global breast imaging market holds a significant share of the medical device industry owing to rising awareness about the early screening of breast cancer. Though digital Mammography is the gold standard in the current breast imaging market, modalities such as breast MRI Scans, breast ultrasound and CTs are expected to drastically improve the breast Imaging Market scenario.
